Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine. 2017

Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
Plum Island Animal Disease Center, ARS, USDA, Greenport, NY 11944, USA; Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, CT 06269, USA.

A human adenovirus (Ad5) vectored foot-and-mouth disease virus (FMDV) O1-Manisa subunit vaccine (Ad5-O1Man) was engineered to deliver FMDV O1-Manisa capsid and capsid-processing proteins. Swine inoculated with Ad5-O1Man developed an FMDV-specific humoral response as compared to animals inoculated with an empty Ad5-vector. Vaccinated animals were completely protected against homologous challenge at 7 or 21 days post-vaccination. Potency studies exhibited a PD50 of about 107 pfu/animal while a dose of 4×107pfu/animal fully protected swine against FMDV intradermal challenge. In-vitro cross-neutralization analysis distinctly predicted that swine vaccinated with Ad5-O1Man would be protected against challenge with homologous FMDV O1Man Middle East-South Asia (ME-SA) topotype and also against recent outbreak strains of Mya-98 South East Asia (SEA) lineage including O1-UK-2001 and O1-South Korea-2010. These results indicate that recombinant Ad5-O1Man is an effective, safe and cross-reacting vaccine that could potentially be used preventively and in outbreak situations, to control FMDV O Mya-98 lineage in swine.

UI MeSH Term Description Entries
D005536 Foot-and-Mouth Disease A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet. Foot and Mouth Disease,Disease, Foot-and-Mouth,Diseases, Foot-and-Mouth,Foot-and-Mouth Diseases
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000257 Adenoviridae Infections Virus diseases caused by the ADENOVIRIDAE. Adenovirus Infections,Infections, Adenoviridae,Infections, Adenovirus,Adenoviridae Infection,Adenovirus Infection,Infection, Adenoviridae,Infection, Adenovirus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013553 Swine Diseases Diseases of domestic swine and of the wild boar of the genus Sus. Disease, Swine,Diseases, Swine,Swine Disease
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral

Related Publications

Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
February 2001, Vaccine,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
July 2005, Virology,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
February 2011, Vaccine,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
December 2023, Emerging microbes & infections,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
April 2018, Vaccine,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
April 2013, Vaccine,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
January 2023, Frontiers in microbiology,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
November 2016, Veterinary immunology and immunopathology,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
November 2005, Biotechnology letters,
Ignacio Fernandez-Sainz, and Gisselle N Medina, and Elizabeth Ramirez-Medina, and Marla J Koster, and Marvin J Grubman, and Teresa de Los Santos
January 2013, Clinical and vaccine immunology : CVI,
Copied contents to your clipboard!